Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

9.235 -0.525 (-5.38%)

Delayed Quote Updated: 10:20 AM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 22, 2022

Via Benzinga

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

Barclays Downgrades Gossamer Bio: Here's What You Need To Know ↗

December 07, 2022

Via Benzinga

What 9 Analyst Ratings Have To Say About Gossamer Bio ↗

December 07, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Gossamer Bio ↗

November 17, 2022

Via Benzinga

Analyst Ratings for Gossamer Bio ↗

November 17, 2022

Via Benzinga

Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday ↗

December 08, 2022

Via Benzinga

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗

December 07, 2022

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...

Via Benzinga

4 Analysts Have This to Say About Gossamer Bio ↗

November 17, 2022

Via Benzinga

What 5 Analyst Ratings Have To Say About Gossamer Bio ↗

October 20, 2022

Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:

Via Benzinga

ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday ↗

December 07, 2022

Barclays raised ConocoPhillips (NYSE: COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $115.61...

Via Benzinga

Dow Dips Over 500 Points; Nasdaq Down 2.5% ↗

December 06, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 2.5% on Tuesday.

Via Benzinga

Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis ↗

December 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 06, 2022

Via Benzinga

Souring Sentiment On Wall Street Sends Dow Down Triple Digits ↗

December 06, 2022

Doubts over the Fed's next move are being compounded with renewed recession anxieties, and this sour sentiment is weighing on markets this afternoon.

Via Talk Markets

Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗

December 06, 2022

Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...

Via Benzinga

S&P 500 Down Over 1%; Crude Oil Falls Sharply ↗

December 06, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday.

Via Benzinga

President Biden Is Bringing Taiwan Semi (TSM) Stock a HUGE Catalyst ↗

December 06, 2022

Taiwan Semiconductor (TSM) stock is on the move Tuesday as investors prepare for President Joe Biden to visit the company's Arizona plant.

Via InvestorPlace

Meta Platforms, Herbalife And Some Other Big Stocks Moving Lower On Tuesday ↗

December 06, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today? ↗

December 06, 2022

GOSS stock is plunging over 70%. The company's hypertension drug reportedly failed to perform better than a competing treatment.

Via InvestorPlace

Dow Drops 100 Points; US Trade Deficit Widens In October ↗

December 06, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.

Via Benzinga

Gossamer Bio Shares Plummet As Hypertension Trial Fall Short Of Expectation ↗

December 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 06, 2022

Via Benzinga

Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH

December 06, 2022

From Gossamer Bio, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

November 30, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial ↗

November 17, 2022

Via Benzinga

Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update

November 03, 2022

From Gossamer Bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022 ↗

October 20, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 ↗

September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.